Search Results - mark+kohler

3 Results Sort By:
Logic Gated CAR-T Therapy for Pediatric Brain Tumors
Diffuse Intrinsic Pontine Glioma DIPG (Diffuse Intrinsic Pontine Glioma) is a highly aggressive brain tumor in children, primarily located in the pons region. It's inoperable due to the tumor’s location, and chemotherapy agents have the inability to cross the blood-brain barrier. Radiation offers only temporary relief, and the 5-year survival...
Published: 12/1/2023   |   Inventor(s): Sujatha Venkataraman, Mark Kohler
Disease Areas Pediatrics
Category(s): Therapeutics
Novel Costimulatory Platform for CAR-Based Adoptive Cell Therapies
Ineffective targeting of current CAR T Chimeric antigen receptor (CAR) T cell therapy is a powerful treatment tool for multiple types of malignancies. There are six FDA approved CAR T therapies that have demonstrated efficacy in patients who are refractory to standard chemotherapy, with many patients entering remission after treatment. However, most...
Published: 10/23/2023   |   Inventor(s): Mark Kohler, Terry Fry, Catherine Danis, Lillie Leach
Disease Areas Regenerative Medicine
Category(s): Therapeutics
Novel Costimulatory Platform for CAR-Based Adoptive Cell Therapies
Ineffective targeting of current CAR T Chimeric antigen receptor (CAR) T cell therapy is a powerful treatment tool for multiple types of malignancies. There are six FDA approved CAR T therapies that have demonstrated efficacy in patients who are refractory to standard chemotherapy, with many patients entering remission after treatment. However, most...
Published: 10/23/2023   |   Inventor(s): Mark Kohler, Catherine Danis, Terry Fry, Lillie Leach
Disease Areas Regenerative Medicine
Category(s): Therapeutics
For inquiries, email: cuinnovations@cuanschutz.edu.     © 2024. All Rights Reserved. Powered by Inteum